Gland Pharma P/E Ratio
Gland Pharma P/E ratio. Gland Pharma (GLAND) P/E ratio is 45.1 (High), EPS (TTM) ₹62.35, current price ₹3292.90 on NSE vs historical average P/E of 41.09 (83.3th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Gland Pharma share price screener.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
GLAND P/E Ratio — Valuation Signal & Historical Context
Gland Pharma P/E 45.1 vs historical average 41.09, range 30.45–64.12 — signal: Overvalued. Check GLAND market cap trends to track the company's total market size over time.
- Stock appears overvalued with PE of 45.1, suggesting caution for new investments
- Trading at discount to sector average PE of 52.22
Gland Pharma P/E Ratio Historical Trend
GLAND annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 45.1 vs historical average 41.09. Also explore GLAND stock price history to track price trends across different timeframes.
GLAND Historical P/E Ratio — EPS, Year-End Price & Valuation
Gland Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 35.2 | 51.42 | ₹1810.10 | NSE | High |
| 2024 | 44.59 | 42.76 | ₹1906.55 | NSE | High |
| 2023 | 39.4 | 40.0 | ₹1575.90 | NSE | High |
| 2022 | 64.12 | 60.06 | ₹3851.30 | NSE | High |
| 2021 | 32.76 | 72.33 | ₹2369.70 | NSE | High |
| 2020 | 30.45 | 59.76 | ₹1819.55 | NSE | High |
GLAND vs Healthcare Peers — P/E Ratio Comparison
Gland Pharma P/E 45.1 vs Healthcare average 52.22, median 29.4 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |